Study of the photocatalytic effects of nitrogen-doped titanium dioxide nanoparticles on growth inhibition and apoptosis induction in K562 cell line

Scientific Journal of Kurdistan University of Medical Sciences

Volumn 18, Issue 1, 2013, Pages 47-58

  Moosavi, Seyed Mohammad Amin ^a   Khataee, Alireza ^a   Moasses Ghafari, Soroosh ^a  

^a UNIVERSITY OF TABRIZ   (Iran)

Author keywords

Apoptosis; K562; Nitrogen doped titanium dioxid; Photocatalysis

Indexed keywords

NANOPARTICLE; NITROGEN; TITANIUM DIOXIDE;

APOPTOSIS; ARTICLE; CHRONIC MYELOID LEUKEMIA; DNA FRAGMENTATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PHOTOCATALYSIS; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION;

EID: 84911911894     PISSN: 1560652X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Reddy BM, Ganesh I, Khan A. Stabilization of nanosized titania-anatase for high temperature catalytic applications. J Mol Catal A Chem 2004; 223: 295-304.
2. Fujishima A, Zhang X. Titanium dioxide photocatalysis: present situation and future approaches. C R Chemie 2006; 9: 750-60.
3. Kasem KK, Dahn M. Photodissociation of water using colloidal nanoparticles of doped titanium (IV) oxide semiconductors for hydrogen production. Curr Sci 2010; 99: 1068-73.
4. Wang ML, Tuli R, Manner PA, Sharkey PF, Hall DJ, Tuan RS. Direct and indirect induction of apoptosis in human mesenchymal stem cells in response to titanium particles. J Orthop Res 2003; 21: 697-707.
5. Wang JJ, Sanderson BJ, Wang H. Cyto-and geno-toxicity of ultrafine TiO2 particles in cultured human lymphoblastoid cells. Mutat Res 2007; 628: 99-106.
6. Lagopati N, Kitsiou PV, Kontos AI, Venieratos P, Kotsopoulou E, Kontos AG and et al. Photo-induced treatment of breast epithelial cancer cells using nanostructured titanium dioxide solution. J Photochem Photobiol A 2010; 214: 215-23.
7. Lee YS, Yoon S, Yoon HJ, Lee K, Yoon HK, Lee JH and et al. Inhibitor of differentiation 1 (Id1) expression attenuates the degree of TiO2-induced cytotoxicity in H1299 non-small cell lung cancer cells. Toxicol Lett 2009; 189: 191-9.
8. Rahmani AR, Samarghandi MR, Samadi MT, Nazemi F. Photocatalytic disinfection of coliform bacteria using UV/TiO2. J Res Health Sci 2009; 9: 1-6.
9. Khataee AR, Fathinia M, Aber S, Zarei M. Optimization of photocatalytic treatment of dye solution on supported TiO2 nanoparticles by central composite design: Intermediates identification. J Hazard Mater 2010; 181, 886-97.
10. Khataee AR, Zarei M, Fathinia M, Khobnasab Jafari M. Photocatalytic degradation of an anthraquinone dye on immobilized TiO2 nanoparticles in a rectangular reactor: destruction pathway and response surface approach. Desalination 2011; 268:126-33.
11. Zaleska A. Characteristics of doped-TiO2 photocatalysts. Physicochem Probl Mi 2008; 42: 211-22.
12. Asahi R, Morikawa T, Ohwaki T, Aoki K, Taga Y. Visible-light photocatalysis in nitrogen-doped titanium oxides. Science 2001; 293: 269-71.
13. Sakthivel S, Kisch H. Daylight photocatalysis by carbon-modified titanium dioxide. Chem Int Ed 2003; 42: 4908-11.
14. Umebayashi T, Yamaki T, Yamamoto S, Miyashita A, Tanaka S, Sumita T and et al. Sulfur-doping of rutile-titanium dioxide by ion implantation: Photocurrent spectroscopy and first-principles band calculation studies. J Appl Phys 2003; 93: 5156-60.
15. Ho W, Yu JC, Lee S. Synthesis of hierarchical nanoporous F-doped TiO2 spheres with visible light photocatalytic activity. Chem Commun 2006;14: 1115-7.
16. Huan YU, Xuxu Z, Zhongyi Y, Feng T, Beibei F and Keshan H. Preparation of nitrogendoped Ti02 nanoparticle catalyst and its catalytic activity under visible light. Chin J Chern Eng 2007; 15: 802-7.
17. D Mitoraj, H Kisch. On the mechanism of urea-induced titania modification. Chem Eur J 2010; 16: 261-9.
18. E Farfan-Arribas, R J Madix. Characterization of the acid-base properties of the TiO2 (110) surface by adsorption of amines. J Phys Chem 2003; 107: 3225-33.
19. Li M, Huang QZ, Qiu DF, JiaoZJ, Meng ZH, Shi HZ. Study on anti-fungal activity of nitrogen-doped TiO2 nanophotocatalyst under visible light irradiation. Chin Chem Lett 2010; 21: 117-21.
20. Liu Y, Li J, Qiu X, Burda C. Bactericidal activity of nitrogen-doped metal oxide nanocatalysts and the influence of bacterial extracellular polymeric substances (EPS). J Photochem Photobiol 2007; 190: 94-100.
21. Li Z, Mi L, Wang PN, Chen JY. Study on the visible-light-induced photokilling effect of nitrogen-doped TiO2 nanoparticles on cancer cells. Nanoscale Res Lett 2011; 6: 356-62.
22. Patterson A L. The scherrer formula for X-ray particle size determination. Phys Rev 1939; 56: 978-82.
23. Moosavi MA, Moasses Ghafary S, Asadi M, Asvadi Kermani I. Growth inhibitory and apoptotic effects of carbenoxolone in human leukemia K562 cell line. SJKU 2011; 16: 27-37.
24. An X, Tiwari AK, Sun Y, Ding PR, Ashby Jr CR, Chen ZS. BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: A review. Leuk Res 2010; 34:1255-68.
25. Faderl S, Talpaz M, Estrov Z, Kantarjian HM. Chronic Myelogenous Leukemia: Biology and Therapy. Ann Intern Med 1999; 131: 207-19.
26. Radivoyevitch T, Kozubek S, Sachs RK. Commentary the risk of chronic myeloid leukemia: can the dose-response curve be u-shaped? Radiat Res 2002; 157: 106-9.
27. Mauro MJ, Maziarz RT. Stem cell transplantation in patients with chronic myelogenous leukemia: when should it be used? Mayo Clin Proc 2006; 81: 404-16.
28. Fausel C. Targeted chronic myeloid leukemia therapy: Seeking a Cure. JMCP 2007; 13; S8-S12.
29. Bruserud O, Gjertsen BT. New strategies for the treatment of acute myelogenous leukemia: differentiation induction-present use and future possibilities. Stem Cells 2000; 18: 157-65.
30. Lazau C, Mocanu L, Miron I, Sfirloaga P, Tanasie G, Tatu C and et al. Consideration regarding the use of TiO2 Doped nanoparticles in medicine. Dig J Nanomater Bios 2007; 2: 257-63.
31. Bregoli L, Chiarini F, Gambarelli A, Sighinolfi G, Gatti AM, Santi P and et al. Toxicity of antimony trioxide nanoparticles on human hematopoietic progenitor cells and comparison to cell lines. Toxicology 2009; 262: 121-9.
32. Xian-ying C, Hong-lian D, Yu-hua Y, Shi-pu L. Selective anti-hepatoma treated with titanium oxide nanoparticles In vitro. J Wuhan Univ Technol 2003; 18: 52-4.
33. Moosavi MA, Yazdanparast R, Sanati MH. The cytotoxic and anti-proliferative effects of 3-Hydrogenkwadaphnin in K562 and Jurkat cells is reduced by guanosine. J Bio Chem Mol Biol 2005; 38: 391-8.
34. Mirkina II, Mernenko OA, Satpaev DK, Karelin AA, Blishchenko EY. Cytolytic processes induced by TNF in L929 and K562 differ in DNA fragmentation mechanisms. Immunol Lett 1996; 52: 105-8.
35. Wang L, Mao J, Zhang GH, Tu MJ. Nano-cerium-element-doped titanium dioxide induces apoptosis of Bel 7402 human hepatoma cells in the presence of visible light. World J Gastroenterol 2007; 13: 4011-4.
36. Harada Y, Ogawa K, Irie Y, Endo H, Feril LB Jr, Uemura T and et al. Ultrasound activation of TiO2 in melanoma tumors. J Control Release 2011; 149:190-5.